News

Curis Inc. Upcoming Presentation at Healthcare Conference

Curis Inc. Upcoming Presentation at Healthcare Conference

Curis Inc. Upcoming Presentation at Healthcare Conference

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on pioneering the development of emavusertib (CA-4948), an innovative orally administered small molecule IRAK4 inhibitor, has recently made an announcement regarding its participation in a notable healthcare and technology conference.

Fireside Chat Participation by CEO

At the Jones Healthcare and Technology Innovation Conference, James Dentzer, the President and CEO of Curis, will engage in a captivating fireside chat as well as deliver a company presentation. The conference is set to highlight the significant advancements and future potential of emavusertib in oncology.

All Bets on IRAK4 Fireside Chat

During this fireside chat, attendees will have the opportunity to gain insights into the transformative potential of IRAK4 inhibitors in targeted cancer therapies. The chat is scheduled to commence at 4:30 PM ET (1:30 PM PT), providing a platform for in-depth discussions regarding Curis's strategic direction and the future of emavusertib.

Curis's Company Presentation Details

Following the fireside chat, Curis will hold a company presentation at 5:00 PM ET (2:00 PM PT). This presentation will cover the company’s recent developments, focusing on clinical pipeline updates and their strategic initiatives within the biopharmaceutical landscape. Attendees are encouraged to participate in this session to learn more about Curis's groundbreaking work.

Joining the Conference Online

For those unable to attend in person, an opportunity to view the fireside chat and company presentation will be available through a live webcast. Participants can conveniently access this via the Curis investor relations webpage.

The Significance of Emavusertib

Curis is directing its efforts toward advancing emavusertib through various clinical trials, showcasing its potential against conditions like lymphoma and leukemia. The drug is currently under evaluation in the Phase 1/2 TakeAim Lymphoma study, which aims to assist patients dealing with relapsed or refractory primary central nervous system lymphoma. Furthermore, emavusertib is being analyzed as part of monotherapy and combination therapy studies, highlighting its versatility in treating acute myeloid leukemia and high-risk myelodysplastic syndrome.

About Curis, Inc.

Curis is committed to not only pioneering the development of innovative therapies like emavusertib, but also prioritizing patient needs by focusing on hard-to-treat cancers. This dedication has earned the drug Orphan Drug Designation from the U.S. FDA for multiple indications, marking a critical recognition of its therapeutic potential. With an exclusive license to emavusertib in collaboration with Aurigene, Curis is poised to make significant contributions to oncology.

Frequently Asked Questions

What is emavusertib?

Emavusertib is an orally available, small molecule IRAK4 inhibitor that is under development for treating various forms of cancer, including lymphoma and leukemia.

When will the fireside chat take place?

The fireside chat is scheduled for 4:30 PM ET on the day of the conference.

How can I access the presentations?

The live webcast and archived presentations will be available on the Curis investor relations website.

What are some of the clinical trials involving emavusertib?

Emavusertib is currently involved in trials like the Phase 1/2 TakeAim studies for lymphoma and leukemia.

What is the focus of Curis, Inc.?

Curis focuses on developing innovative treatments for cancers, particularly through targeted therapies with the potential to improve patient outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Clifford Law Offices: Top Tier Legal Heavyweights in 2027

Updated Category News Views 73

Clifford Law Offices: Winning Through Thick and Thin Well, when you hear about a law firm rubbing shoulders with the elite in the legal arena, you know they've got a story buried in cases strewn with complexity and triumph. Clifford Law Offices has etched its name in the 2027 edition of Best Law Firms®. They're not just coasting on past laurels; they're constantly...

Continue Reading
Unbound Merino Strategizes Expansion with Centric PLM

Updated Category News Views 99

Merino Wool Meets Tech: What’s the Big Deal? So here we are, talking about wool and tech. Not exactly two peas in a pod, right? Unbound Merino, a brand with its roots in Toronto, decided to shake things up. Founded by three buddies in 2016, they're all about crafting premium wool apparel for the globetrotters and everyday folks alike. With an expanding lineup and sales...

Continue Reading
Shackleton AI Tackles Construction with $5M Boost

Updated Category News Views 91

Sweeping Away Construction's Admin Grit Dive headfirst into the realm of construction, and you'd think you're imitating a 20th-century manual dance—a mishmash of paper trails and stray spreadsheets. Shackleton AI is aiming to drag this business into the 21st century by ditching those clunky methods. The New York-based startup threw its hat into the tech ring with what...

Continue Reading
Ivonescimab Receives Priority Review for BTC in China

Updated Category News Views 46

A New Chapter for Biliary Tract Cancer Treatment In the world of cancer treatment, gaining a regulatory nod often feels like hitting a tough milestone. Well, Akeso, Inc. is now basking in one of those high notes. Their flagship drug, ivonescimab, has snatched up a Priority Review from China's National Medical Products Administration (NMPA) for first-line treatment of...

Continue Reading
ACR Poker Rolls Out Big Update: ScreenShield Goes Live

Updated Category News Views 99

ACR Poker's Revamp: What's New? ACR Poker decided to shake things up with a software update rolled out on November 4. This wasn't some minor tinkering under the hood, folks. We're talking about a full-blown revamp aimed at making players' lives a breeze while keeping security airtight. The hot potato here? The ScreenShield feature now riding shotgun automatically for all...

Continue Reading
BSA Unveils 2027 Board: Steering Architecture's Future

Updated Category News Views 30

Fresh Faces Navigate a Storied Institution In this unpredictable dance of leadership, the Boston Society of Architects (BSA) just laid its cards on the table for 2027. The latest board of directors and governance committees were announced with the kind of precision that shows how serious these folks are about preparing for a future that's anything but predictable. Handing...

Continue Reading
Aberlour Elevates U.S. Market with New Whisky Launches

Updated Category News Views 31

Aberlour's Bold U.S. Expansion Aberlour isn't just gently knocking on the U.S. market's door; they're making a hefty entry with a couple of heavy hitters—a 14-Year-Old and a 21-Year-Old single malt Scotch whisky. And trust me when I say, they've got their eyes on being top-shelf material. It seems they're not tiptoeing into the States; they're striding in with...

Continue Reading
Jungbunzlauer Introduces Johan Westman to Its Board

Updated Category News Views 58

A Strategic Addition to Jungbunzlauer’s Board In what feels like a significant move, Jungbunzlauer has roped in Johan Westman to join its Board of Directors. The man’s got pedigree—a CEO at AAK AB, a Swedish powerhouse dealing in plant-based oils, he's taking a seat at Jungbunzlauer’s table. So, what does this mean for Jungbunzlauer? Well, the potential for...

Continue Reading
Sabre's Q3 Earnings: What Investors Need to Know

Updated Category News Views 71

Unpacking Sabre's Latest Financial Reveal Sabre Corporation, that familiar name in travel tech, let the third quarter numbers out of the bag. Published fresh off the wire on November 5th, this round of figures covers the books up until September 30, 2026. If you're wired into NASDAQ:SABR, this is your bread and butter for the quarter. The figures, straight from Sabre's...

Continue Reading
Flip It Homes Boosts LA Property Value Using ADUs

Updated Category News Views 47

Backyards Aren't Just for Barbecues Anymore Picture this: Los Angeles homeowners turn their underutilized backyards into cold, hard cash. It's a Mad Max real estate scenario out there, with everyone scrambling to grab their piece of the pie. While some might be eyeing more traditional investments, savvy Angelenos are tapping into the potential jungle beyond their backdoor...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing the Future of Stock Market Gains Amid Economic Changes

Updated Category News Views 124

Understanding the Current State of the Equity Market By examining the varying dynamics within the stock market, it's essential to acknowledge how large technology companies have significantly influenced Wall Street's upward trajectory throughout the year. However, there is a notable shift occurring, driven by expectations of aggressive interest rate adjustments, allowing...

Continue Reading
TransMedics Set to Showcase Innovations at Major Conference

Updated Category News Views 105

TransMedics Announces Upcoming Conference Participation TransMedics Group, Inc. (Nasdaq: TMDX), a pioneering medical technology company, is gearing up to make a significant impact at a major upcoming event. The company, dedicated to revolutionizing organ transplant therapy for patients suffering from severe heart, lung, and liver conditions, has announced its...

Continue Reading
Pecan Tree Family Dentistry Expands Dental Services

Updated Category News Views 187

Pecan Tree Family Dentistry Introduces a Complete Range of Dental Services Pecan Tree Family Dentistry, a prominent dental practice, is thrilled to announce the launch of its extensive selection of dental services. This includes advanced cosmetic dentistry options such as veneers, teeth whitening, and Invisalign, all designed to provide families with a full spectrum of...

Continue Reading
Investors Should Seek Justice Against Blue Owl Capital Mismanagement

Updated Category News Views 152

Understanding the Situation with Blue Owl Capital Inc. For investors who have faced losses with Blue Owl Capital Inc. (NYSE: OWL), there’s crucial information to consider. This article addresses the implications of potentially misleading statements made by the company and highlights steps for affected investors to take. Who Should Take Action? If you acquired shares in...

Continue Reading
BigBear.ai Stock Insights: Navigating Recent Fluctuations

Updated Category News Views 216

Current Status of BigBear.ai (BBAI) Stock BigBear.ai Holdings Inc (NYSE: BBAI) is witnessing an upswing in its shares this week, rebounding after a tumultuous period that saw the stock decline by nearly 13% over just five days. This fluctuation included a notable 8% dip earlier in the week. Investors are showing caution as they await significant economic indicators and...

Continue Reading